ImmunityBio Inc

IBRXNASDAQ · USD
8.44USD0.00 (-2.32%)
1210

ImmunityBio Inc (IBRX) Option Chain

As of September 24, 2026, ImmunityBio Inc is trading at $8.44, a -2.32% change from the previous close. The nearest expiration is Oct 2, 2026. Implied volatility is 85.7%. IV Rank is 14%.

Read more

Tracking the IBRX option chain helps you see every strike and expiry on ImmunityBio Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. ImmunityBio Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IBRX options activity at a glance. Use our scanner to monitor the IBRX option chain in real time and filter for the IBRX options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IBRX stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IBRX option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IBRX stock options are being actively traded and where they are not.

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The company also develops therapeutic agents, which are in Phase II or III clinical trial for the treatment of liquid and solid tumors, including bladder, pancreatic, and lung cancers, as well as pathogens as SARS-CoV-2 and HIV. It has collaboration agreements with National Cancer Institute, National Institute of Deafness and Communication Disorders, and Amyris, Inc.; and license agreements with CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co.

Ltd., Sorrento Therapeutics, Inc., and Viracta Therapeutics, Inc. The company was founded in 2014 and is based in San Diego, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls ImmunityBio Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen IBRX options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IBRX stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile47.22% Neutral
  • Market cap (M$)8,945
  • 52 weeks high-32.10%
  • 52 weeks low332.82%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$12.75
    51.07% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-03
  • P/E—
  • Future P/E—
  • EPS (ttm)-0.97
  • EPS growth next 5 years—

As of September 24, 2026

2026-10-02
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
16.752200.140.940.451.707.50-11.140.050.200.000.131138483.25
34.13721260.540.440.501.458.00-5.210.050.700.000.381589765.87
54.481,0037740.350.000.300.408.50+0.710.250.450.060.291261,02545.52
72.721,0925350.200.000.150.259.00+6.640.501.000.560.19235927.28
85.761,103750.130.000.100.159.50+12.560.052.951.060.4401614.24

As of September 24, 2026

Scan the full option chain in one place

Browse the full IBRX option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial